Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel: +47 21 07 81 60
E-mail:

Copyright/Disclaimer

New DDDs

ATC code	ATC level name	New DDD


A07AA13	rifamycin	0.8 ¹⁾	g	O
A10BH08	teneligliptin	20	mg	O
B06AX04	mitapivat	0.1	g	O
C03DA05	finerenone	20	mg	O
G04BD15	vibegron	75	mg	O
H02CA02	osilodrostat	10	mg	O
H05BX06	evocalcet	2.5	mg	O
J01AA13	eravacycline	0.14	g	P
J01DC52	cefuroxime and beta-lactamase inhibitor	0.5 ²⁾	g	O
J01DI04	cefiderocol	6	g	P
J02AA01	amphotericin B	210 ³⁾	mg	P
J02AC06	oteseconazole	21	mg	O
J04AK08	pretomanid	0.2	g	O
J05AE16	ensitrelvir	0.175	g	O
J05AH04	laninamivir	0.16	g	Inhal.solution
J05AP13	ravidasvir	0.2	g	O
J05AX10	maribavir	0.8	g	O
J05AX24	tecovirimat	1.2	g	O
J05AX28	bulevirtide	2	mg	P
J05AX31	lenacapavir	0.19	g	O
J05AX31	lenacapavir	5.1	mg	P
L01EA06	asciminib	80	mg	O
L01EL04	orelabrutinib	0.15	g	O
L01EX21	tepotinib	0.45	g	O
L04AA03	antilymphocyte immunoglobulin (horse)	1.05	g	P
L04AC19	satralizumab	4.3	mg	P
L04AC22	spesolimab	0.9 ⁴⁾	g	P
L04AD03	voclosporin	47.4	mg	O
L04AG11 ⁵⁾	anifrolumab	10.7	mg	P
L04AJ03 ⁶⁾	pegcetacoplan	0.3	g	P
N02CC08	lasmiditan	0.1	g	O
N02CD05	eptinezumab	1.1	mg	P
R05DB29	gefapixant	90	mg	O
V03AX04	difelikefalin	15	mcg	P

1) as sodium salt
2) refers to cefuroxime
3) lipid formulations
4) course dose
5) Previous ATC code L04AA51. New ATC 4th level L04AG valid from January 2024.
6) Previous ATC code L04AA54. New ATC 4th level L04AJ valid from January 2024.

Last updated: 2023-12-12